Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian Cells

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Reverdatto, Sergey ^a   Rai, Vivek ^b   Xue, Jing ^a   Burz, David S ^a   Schmidt, Ann Marie ^b   Shekhtman, Alexander ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PEPTIDE APTAMER; THIOREDOXIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL ASSAY; COMBINATORIAL LIBRARY; CONTROLLED STUDY; MALE; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SOLUBILITY; TWO HYBRID SYSTEM;

ANIMALS; APTAMERS, PEPTIDE; CELL LINE; MALE; MICE; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; RATS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SOLUBILITY; THIOREDOXINS; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 84878976908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065180     Document Type: Article

References (69)

1. Nimjee SM, Rusconi CP, Sullenger BA, (2005) Aptamers: an emerging class of therapeutics. Annu Rev Med 56: 555-583.
2. Tuerk C, Gold L, (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
3. Ellington AD, Szostak JW, (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
4. Roberts RW, Szostak JW, (1997) RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci U S A 94: 12297-12302.
5. Georgiou G, Stathopoulos C, Daugherty PS, Nayak AR, Iverson BL, et al. (1997) Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nat Biotechnol 15: 29-34.
6. Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, et al. (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5: 123-132.
7. Huber D, Cha MI, Debarbieux L, Planson AG, Cruz N, et al. (2005) A selection for mutants that interfere with folding of Escherichia coli thioredoxin-1 in vivo. Proc Natl Acad Sci U S A 102: 18872-18877.
8. Smith GP, (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228: 1315-1317.
9. Mattheakis LC, Bhatt RR, Dower WJ, (1994) An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci U S A 91: 9022-9026.
10. Rodi DJ, Soares AS, Makowski L, (2002) Quantitative assessment of peptide sequence diversity in M13 combinatorial peptide phage display libraries. J Mol Biol 322: 1039-1052.
11. Menendez A, Scott JK, (2005) The nature of target-unrelated peptides recovered in the screening of phage-displayed random peptide libraries with antibodies. Anal Biochem 336: 145-157.
12. Vodnik M, Zager U, Strukelj B, Lunder M, (2011) Phage display: selecting straws instead of a needle from a haystack. Molecules 16: 790-817.
13. Thomas WD, Golomb M, Smith GP, (2010) Corruption of phage display libraries by target-unrelated clones: diagnosis and countermeasures. Anal Biochem 407: 237-240.
14. Newton-Northup JR, Deutscher SL, (2012) Contending With Target Unrelated Peptides from Phage Display. J Mol Imaging Dynam 2: 1-3.
15. Derda R, Tang SK, Li SC, Ng S, Matochko W, et al. (2011) Diversity of phage-displayed libraries of peptides during panning and amplification. Molecules 16: 1776-1803.
16. Crawford M, Woodman R, Ko Ferrigno P, (2003) Peptide aptamers: tools for biology and drug discovery. Brief Funct Genomic Proteomic 2: 72-79.
17. Bickle MB, Dusserre E, Moncorge O, Bottin H, Colas P, (2006) Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures. Nat Protoc 1: 1066-1091.
18. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, et al. (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380: 548-550.
19. Cohen BA, Colas P, Brent R, (1998) An artificial cell-cycle inhibitor isolated from a combinatorial library. Proc Natl Acad Sci U S A 95: 14272-14277.
20. Klevenz B, Butz K, Hoppe-Seyler F, (2002) Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding. Cell Mol Life Sci 59: 1993-1998.
21. Christ D, Famm K, Winter G, (2006) Tapping diversity lost in transformations - in vitro amplification of ligation reactions. Nucleic Acids Res 34: e108.
22. Borghouts C, Kunz C, Delis N, Groner B, (2008) Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Mol Cancer Res 6: 267-281.
23. Brown CJ, Dastidar SG, See HY, Coomber DW, Ortiz-Lombardia M, et al. (2010) Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide grafting. J Mol Biol 395: 871-883.
24. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, et al. (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274: 31740-31749.
25. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360.
26. Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, et al. (2001) Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 21: 905-910.
27. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
28. Yan SD, Chen X, Fu J, Chen M, Zhu H, et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
29. Koch M, Chitayat S, Dattilo BM, (2010) Schiefner A, Diez J, et al (2010) Structural basis for ligand recognition and activation of RAGE. Structure 18: 1342-1352.
30. Fritz G, (2011) RAGE: a single receptor fits multiple ligands. Trends Biochem Sci 36: 625-632.
31. Xie J, Burz DS, He W, Bronstein IB, Lednev I, et al. (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 282: 4218-4231.
32. Colas P, (2000) Combinatorial protein reagents to manipulate protein function. Curr Opin Chem Biol 4: 54-59.
33. Xue J, Rai V, Singer D, Chabierski S, Xie J, et al. (2011) Advanced glycation end product recognition by the receptor for AGEs. Structure 19: 722-732.
34. James P, Halladay J, Craig EA, (1996) Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144: 1425-1436.
35. Studier FW, (2005) Protein production by auto-induction in high-density shaking cultures. Protein Expr Purif 41: 207-234.
36. Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, et al. (2008) Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 283: 27255-27269.
37. Reichelt P, Schwarz C, Donzeau M, (2006) Single step protocol to purify recombinant proteins with low endotoxin contents. Protein Expr Purif 46: 483-488.
38. Bryksin AV, Matsumura I, (2010) Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids. BioTechniques 48: 463-465.
39. Ahmed H (2004) Principles and Reactions of Protein Extraction, Purification, and Characterization. Boca Raton, USA: CRC Press LLC.
40. Eswar N, Eramian D, Webb B, Shen MY, Sali A, (2008) Protein structure modeling with MODELLER. Methods Mol Biol 426: 145-159.
41. Brooks BR, Brooks CL 3rd, Mackerell AD Jr., Nilsson L, Petrella RJ, et al (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30: 1545-1614.
42. Luthy R, Bowie JU, Eisenberg D, (1992) Assessment of protein models with three-dimensional profiles. Nature 356: 83-85.
43. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 26: 283-291.
44. Cavanagh J, Fairbrother WJ, Palmer AG, Skelton N (1996) Protein NMR Spectroscopy: Principles and Practice. San Diego, CA.: Academic Press.
45. Chandrasekhar G, Krause A, Holmgren A, Dyson HJ, (1991) Assignment of the 15N NMR spectrum of reduced and oxidized Escherichia coli thioredoxin. FEBS Lett 284: 178-183.
46. Dyson HJ, Holmgren A, Wright PE, (1989) Assignment of the proton NMR spectrum of reduced and oxidized thioredoxin: sequence-specific assignments, secondary structure and global fold. Biochemistry 28: 7074-7087.
47. Masse JE, Keller R, (2005) AutoLink: automated sequential resonance assignment of biopolymers from NMR data by relative-hypothesis-prioritization-based simulated logic. J Magn Reson 174: 133-151.
48. de Vries SJ, van Dijk M, Bonvin AM, (2010) The HADDOCK web server for data-driven biomolecular docking. Nat Protoc 5: 883-897.
49. Tarvo P, Barret G, (1980) Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels 17: 110-116.
50. Worthington MT, Pelo J, Luo RQ, (2001) Cloning of random oligonucleotides to create single-insert plasmid libraries. Anal Biochem 294: 169-175.
51. Dower WJ, Miller JF, Ragsdale CW, (1988) High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res 16: 6127-6145.
52. Dean FB, Nelson JR, Giesler TL, Lasken RS, (2001) Rapid amplification of plasmid and phage DNA using Phi 29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res 11: 1095-1099.
53. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113: 1641-1650.
54. Dattilo BM, Fritz G, Leclerc E, Kooi CW, Heizmann CW, et al. (2007) The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46: 6957-6970.
55. Chien CT, Bartel PL, Sternglanz R, Fields S, (1991) The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci U S A 88: 9578-9582.
56. Fields S, Song O, (1989) A novel genetic system to detect protein-protein interactions. Nature 340: 245-246.
57. Takesako K, Ikai K, Haruna F, Endo M, Shimanaka K, et al. (1991) Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties. J Antibiot (Tokyo) 44: 919-924.
58. Langsetmo K, Fuchs JA, Woodward C, Sharp KA, (1991) Linkage of thioredoxin stability to titration of ionizable groups with perturbed pKa. Biochemistry 30: 7609-7614.
59. Langsetmo K, Sung YC, Fuchs JA, Woodward C (1990) Escherichia coli Thioredoxin Stability Is Greatly Enhanced by Substitution of Aspartic Acid 26 by Alanine. In: J.J V, editor. Current research in protein chemistry: Techniques, structure and function. New York: Academic Press. 449-456.
60. Pedone E, Cannio R, Saviano M, Rossi M, Bartolucci S, (1999) Prediction and experimental testing of Bacillus acidocaldarius thioredoxin stability. Biochem J 339 (Pt 2): 309-317.
61. Langsetmo K, Fuchs JA, Woodward C, (1991) The conserved, buried aspartic acid in oxidized Escherichia coli thioredoxin has a pKa of 7.5. Its titration produces a related shift in global stability. Biochemistry 30: 7603-7609.
62. Dyson HJ, Jeng MF, Tennant LL, Slaby I, Lindell M, et al. (1997) Effects of buried charged groups on cysteine thiol ionization and reactivity in Escherichia coli thioredoxin: structural and functional characterization of mutants of Asp 26 and Lys 57. Biochemistry 36: 2622-2636.
63. Walters KJ, Ferentz AE, Hare BJ, Hidalgo P, Jasanoff A, et al. (2001) Characterizing protein-protein complexes and oligomers by nuclear magnetic resonance spectroscopy. Methods Enzymol 339: 238-258.
64. Katti SK, LeMaster DM, Eklund H, (1990) Crystal structure of thioredoxin from Escherichia coli at 1.68 A resolution. J Mol Biol 212: 167-184.
65. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, et al. (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143: 1699-1712.
66. Shi H, Fan X, Sevilimedu A, Lis JT, (2007) RNA aptamers directed to discrete functional sites on a single protein structural domain. Proc Natl Acad Sci U S A 104: 3742-3746.
67. Baines IC, Colas P, (2006) Peptide aptamers as guides for small-molecule drug discovery. Drug Discov Today 11: 334-341.
68. Guex N, Peitsch MC, (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
69. Simossis VA, Heringa J, (2005) PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res 33: W289-294.